Northern Trust’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-512,747
Closed -$3.13M 4833
2021
Q3
$3.13M Sell
512,747
-3,413
-0.7% -$20.8K ﹤0.01% 3034
2021
Q2
$4.25M Buy
516,160
+14,704
+3% +$121K ﹤0.01% 2947
2021
Q1
$4.49M Sell
501,456
-36,529
-7% -$327K ﹤0.01% 2826
2020
Q4
$6.21M Sell
537,985
-19,705
-4% -$227K ﹤0.01% 2549
2020
Q3
$5.81M Buy
557,690
+61,993
+13% +$645K ﹤0.01% 2435
2020
Q2
$6.52M Buy
495,697
+47,848
+11% +$629K ﹤0.01% 2358
2020
Q1
$3.52M Buy
447,849
+1,954
+0.4% +$15.4K ﹤0.01% 2500
2019
Q4
$9.23M Sell
445,895
-14,594
-3% -$302K ﹤0.01% 2227
2019
Q3
$6.31M Buy
460,489
+11,496
+3% +$158K ﹤0.01% 2414
2019
Q2
$5.52M Buy
448,993
+1,529
+0.3% +$18.8K ﹤0.01% 2511
2019
Q1
$5.58M Sell
447,464
-616
-0.1% -$7.69K ﹤0.01% 2499
2018
Q4
$5.07M Sell
448,080
-19,623
-4% -$222K ﹤0.01% 2498
2018
Q3
$8.75M Buy
467,703
+11,650
+3% +$218K ﹤0.01% 2337
2018
Q2
$11.8M Buy
456,053
+29,584
+7% +$765K ﹤0.01% 2157
2018
Q1
$9.56M Buy
426,469
+5,451
+1% +$122K ﹤0.01% 2192
2017
Q4
$10.5M Buy
421,018
+59,669
+17% +$1.49M ﹤0.01% 2150
2017
Q3
$8.74M Sell
361,349
-6,023
-2% -$146K ﹤0.01% 2288
2017
Q2
$7.43M Buy
367,372
+22,107
+6% +$447K ﹤0.01% 2368
2017
Q1
$9.29M Buy
345,265
+6,623
+2% +$178K ﹤0.01% 2170
2016
Q4
$6.44M Buy
338,642
+54,182
+19% +$1.03M ﹤0.01% 2378
2016
Q3
$5.56M Buy
284,460
+46,674
+20% +$912K ﹤0.01% 2456
2016
Q2
$3.56M Buy
237,786
+74,363
+46% +$1.11M ﹤0.01% 2692
2016
Q1
$1.5M Sell
163,423
-22,877
-12% -$210K ﹤0.01% 3111
2015
Q4
$3.59M Buy
186,300
+12,366
+7% +$238K ﹤0.01% 2674
2015
Q3
$2.59M Buy
173,934
+92,288
+113% +$1.37M ﹤0.01% 2886
2015
Q2
$1.79M Buy
81,646
+8,406
+11% +$184K ﹤0.01% 3117
2015
Q1
$1.65M Buy
73,240
+11,719
+19% +$264K ﹤0.01% 3228
2014
Q4
$1.24M Buy
61,521
+10,934
+22% +$221K ﹤0.01% 3320
2014
Q3
$923K Buy
50,587
+1,797
+4% +$32.8K ﹤0.01% 3436
2014
Q2
$658K Buy
48,790
+28,096
+136% +$379K ﹤0.01% 3525
2014
Q1
$341K Buy
+20,694
New +$341K ﹤0.01% 3647